Zobrazeno 1 - 10
of 70
pro vyhledávání: '"W. Schlech"'
Autor:
W. Seifert, M Peeters, Margaret Johnson, J Bell, K De Beule, Brian Gazzard, D Spencer, W Schlech, S Miller, S Tchamouroff, Don Smith, M Youle, G Frechette
Publikováno v:
HIV Medicine. 2:78-83
Objectives To determine whether systemic or deep fungal infections can be prevented, a double-blind, placebo-controlled, phase III trial of itraconazole prophylaxis was undertaken in HIV-infected patients. Methods HIV-1 infected patients with CD4 cou
Publikováno v:
Journal of Applied Bacteriology. 80:174-178
The 16S-23S rRNA internal transcribed spacer region (ITS) in genomic DNA from Listeria species was amplified and sequenced so as to find sequence differences that would allow rapid species and strain differentiation. Agarose gel profiles of amplicons
Publikováno v:
Journal of Clinical Microbiology. 34:15-19
Fifty-one clinical isolates of Listeria monocytogenes (15 isolates from two outbreaks and 36 epidemiologically unrelated isolates) were typed by conventional serotyping, ribotyping (RT), pulsed-field gel electrophoresis (PFGE), and arbitrarily primed
Autor:
D E, Smith, J, Bell, M, Johnson, M, Youle, B, Gazzard, S, Tchamouroff, G, Frechette, W, Schlech, S, Miller, D, Spencer, W, Seifert, M, Peeters, K, De Beule
Publikováno v:
HIV medicine. 2(2)
To determine whether systemic or deep fungal infections can be prevented, a double-blind, placebo-controlled, phase III trial of itraconazole prophylaxis was undertaken in HIV-infected patients.HIV-1 infected patients with CD4 counts300 cells/microL
Autor:
T, Hatchette, R, Hudson, W, Schlech, N, Campbell, J, Hatchette, S, Ratnam, C, Donovan, T, Marrie
Publikováno v:
Canada communicable disease report = Releve des maladies transmissibles au Canada. 26(3)
Autor:
J S, Montaner, A, Rachlis, R, Beaulieu, J, Gill, W, Schlech, P, Phillips, C, Auclair, F, Boulerice, A, Schindzielorz, L, Smaldone
Publikováno v:
Journal of acquired immune deficiency syndromes. 7(9)
The aim of this study was to ascertain the safety profile of didanosine (Videx; ddI) within the Canadian Open Treatment Program. Symptomatic HIV+ subjects with AIDS or ARC or CD4200/mm3 were eligible to receive didanosine if they were either (a) into
Publikováno v:
Canadian journal of public health = Revue canadienne de sante publique. 83(2)
An epidemic of hepatitis B occurring in a rural area of Nova Scotia in 1988 and 1989 was investigated. This epidemic identified injection drug use (IDU) as the major determinant of transmission and was the first highly visible indication of IDU in ru
Publikováno v:
The Journal of infectious diseases. 164(4)
Treatment for recurrent genital herpes using edoxudine 3% cream for 5 days was evaluated in 200 patients in a randomized, multicenter, double-blind, placebo-controlled, clinic-initiated trial. Lesion tenderness was predictive of and more sensitive an
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Arthur White, M. Garten, M. L. V. French, R. B. Kohler, Lawrence J. Wheat, W. Schlech, Z. Brahmi, J. Ho, S. E. Zimmerman, M. Kleiman
Publikováno v:
American Review of Respiratory Disease. 128:65-70
Radioimmunoassays for IgM and IgG histoplasmal antibodies were developed and proved to be specific for their respective immunoglobulin classes, sensitive, and reproducible. Elevated IgM antibodies were detected in 59.8% of patients with histoplasmosi